1. Home
  2. MEDP vs FMS Comparison

MEDP vs FMS Comparison

Compare MEDP & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEDP
  • FMS
  • Stock Information
  • Founded
  • MEDP 1992
  • FMS 1996
  • Country
  • MEDP United States
  • FMS Germany
  • Employees
  • MEDP N/A
  • FMS N/A
  • Industry
  • MEDP Biotechnology: Commercial Physical & Biological Resarch
  • FMS Misc Health and Biotechnology Services
  • Sector
  • MEDP Health Care
  • FMS Health Care
  • Exchange
  • MEDP Nasdaq
  • FMS Nasdaq
  • Market Cap
  • MEDP 13.4B
  • FMS 14.1B
  • IPO Year
  • MEDP 2016
  • FMS 1996
  • Fundamental
  • Price
  • MEDP $587.41
  • FMS $22.62
  • Analyst Decision
  • MEDP Hold
  • FMS Sell
  • Analyst Count
  • MEDP 12
  • FMS 2
  • Target Price
  • MEDP $465.18
  • FMS $30.00
  • AVG Volume (30 Days)
  • MEDP 250.1K
  • FMS 510.1K
  • Earning Date
  • MEDP 10-22-2025
  • FMS 11-04-2025
  • Dividend Yield
  • MEDP N/A
  • FMS 2.52%
  • EPS Growth
  • MEDP 25.36
  • FMS 8.62
  • EPS
  • MEDP 14.32
  • FMS 2.86
  • Revenue
  • MEDP $2,358,373,000.00
  • FMS $23,046,819,198.00
  • Revenue This Year
  • MEDP $21.48
  • FMS N/A
  • Revenue Next Year
  • MEDP $11.90
  • FMS N/A
  • P/E Ratio
  • MEDP $40.93
  • FMS $15.64
  • Revenue Growth
  • MEDP 13.88
  • FMS 2.10
  • 52 Week Low
  • MEDP $250.05
  • FMS $21.42
  • 52 Week High
  • MEDP $625.00
  • FMS $30.46
  • Technical
  • Relative Strength Index (RSI)
  • MEDP 56.07
  • FMS 21.61
  • Support Level
  • MEDP $575.00
  • FMS $22.71
  • Resistance Level
  • MEDP $609.13
  • FMS $23.07
  • Average True Range (ATR)
  • MEDP 16.77
  • FMS 0.40
  • MACD
  • MEDP -4.12
  • FMS -0.22
  • Stochastic Oscillator
  • MEDP 36.56
  • FMS 2.29

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: